VRPX (Virpax Pharmaceuticals) Research & Development: $5.82 Mil (TTM As of Dec. 2024)


What is Virpax Pharmaceuticals Research & Development?

Virpax Pharmaceuticals VRPX Research & Development is $5.82 Mil as of Dec. 2024.

Research & Development is the aggregate amount of research and development expenses during the year. Virpax Pharmaceuticals's Research & Development for the three months ended in Dec. 2024 was $1.11 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was $5.82 Mil.

Virpax Pharmaceuticals  (OTCPK:VRPX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Virpax Pharmaceuticals Research & Development Related Terms

Virpax Pharmaceuticals Research & Development Historical Data

* Premium members only.

The historical data trend for Virpax Pharmaceuticals's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Virpax Pharmaceuticals Research & Development Chart

Virpax Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial 1.29 4.84 10.76 5.12 5.82

Virpax Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.10 1.61 1.96 1.14 1.11

Virpax Pharmaceuticals Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.82 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $5.82 Mil mean?
Virpax Pharmaceuticals (VRPX) has a Research & Development of $5.82 Mil as of Dec. 2024. Research and development expense is the total cost for research and development activities. View historical data on Virpax Pharmaceuticals and its competitors.
Is Virpax Pharmaceuticals' Research & Development too high?
Virpax Pharmaceuticals' current Research & Development is $5.82 Mil.
How does Virpax Pharmaceuticals' Research & Development compare to SYGGF and SCPX?
Virpax Pharmaceuticals' Research & Development of $5.82 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Virpax Pharmaceuticals and its competitors. Virpax Pharmaceuticals's current Research & Development is $5.82 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Virpax Pharmaceuticals stock overvalued right now?
Virpax Pharmaceuticals (VRPX) has a current Research & Development of $5.82 Mil. The current Research & Development is $5.82 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Virpax Pharmaceuticals (VRPX), the current Research & Development is $5.82 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Virpax Pharmaceuticals Business Description

Address 1055 Westlakes Drive, Suite 300, Berwyn, PA, USA, 19312
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.